tulathromycin   Click here for help

GtoPdb Ligand ID: 13691

Synonyms: Draxxin® (veterinary) | tulathromycin A
Compound class: Synthetic organic
Comment: Tulathromycin is a macrolide (triamilide subclass) antibacterial that was developed for use in veterinary medicine [3]. It consists of an equilibrated mixture of a 15-membered and a 13-membered ring component in a 9:1 ratio [2]. We show the structure for tulathromycin A, the 15-membered isomer.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 15
Hydrogen bond donors 7
Rotatable bonds 11
Topological polar surface area 200.9
Molecular weight 806.08
XLogP 2.47
No. Lipinski's rules broken 4

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCNC[C@@]1([C@H](C)O[C@H](C[C@@]1(C)OC)O[C@H]2[C@H](C)[C@H]([C@@](C)(C[C@@H](C)CN[C@H](C)[C@H]([C@@](C)([C@@H](CC)OC(=O)[C@@H]2C)O)O)O)O[C@H]3[C@@H]([C@H](C[C@@H](C)O3)N(C)C)O)O
Isomeric SMILES CCCNC[C@@]1([C@@H](O[C@H](C[C@@]1(C)OC)O[C@H]2[C@@H]([C@H]([C@](C[C@H](CN[C@@H]([C@H]([C@]([C@H](OC(=O)[C@@H]2C)CC)(C)O)O)C)C)(C)O)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)C)C)O
InChI InChI=1S/C41H79N3O12/c1-15-17-42-22-41(50)28(8)53-31(20-39(41,10)51-14)55-33-25(5)35(56-37-32(45)29(44(12)13)18-24(4)52-37)38(9,48)19-23(3)21-43-27(7)34(46)40(11,49)30(16-2)54-36(47)26(33)6/h23-35,37,42-43,45-46,48-50H,15-22H2,1-14H3/t23-,24-,25+,26-,27-,28+,29+,30-,31+,32-,33+,34-,35-,37+,38-,39-,40-,41+/m1/s1
InChI Key GUARTUJKFNAVIK-QPTWMBCESA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
Tulathromycin demonstrates improved activity compared to tilmicosin, against field isolates of Gram-negative bacteria that are the common cause of respiratory tract infections in animals [3]. The MIC90 for antibacterial activity against Mannheimia haemolytica and Pasteurella multocida is 1 μg/ml in vitro [3].
Tulathromycin inhibits bacterial protein synthesis with an IC50 of 0.26 ± 0.05 μM [1].